(The Center Square) – Modernization of “manufacturing technologies and controls through further advanced automation and artificial intelligence” are helping trigger Biogen’s commitment of $2 billion into its North Carolina facilities.

The Fortune 500 company based in Cambridge, Mass., opened its first campus in the Research Triangle Park in 1995. Celebrating the 30 years, the company on Monday said its two campuses will further expand “the antisense oligonucleotide capabilities and infrastructure, establishing clinical and commercial multi-platform fill finish capabilities.”